These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28392019)

  • 41. Regression of uraemic pruritus by cyclosporin treatment in a haemodialysis patient.
    Fusaro M; Munaretto G; Spinello M; Gallieni M
    Nephrol Dial Transplant; 2004 May; 19(5):1338-9. PubMed ID: 15102989
    [No Abstract]   [Full Text] [Related]  

  • 42. Growth hormone levels in uraemic patients on haemodialysis.
    Cantalamessa L; Cremagnani L; Orsatti A; Vigna L; Buccianti G
    Nephrol Dial Transplant; 1992; 7(10):1068-9. PubMed ID: 1331885
    [No Abstract]   [Full Text] [Related]  

  • 43. Chromatographic analysis of middle molecules in plasma ultrafiltrates of uraemic patients.
    Popławski A; Myśliwiec M
    Nephrol Dial Transplant; 1993; 8(2):188. PubMed ID: 8384345
    [No Abstract]   [Full Text] [Related]  

  • 44. Ornithine decarboxylase activity and polyamines level from red cells lysate of uraemic patients and normal healthy subjects.
    Fiocchi O; Stabellini G; Caruso A; Masotti M; Squerzanti R; D'Orazi D; Farinelli A
    Int J Artif Organs; 1987 Nov; 10(6):375-8. PubMed ID: 3443521
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of the super-flux cellulose triacetate dialyser membrane on the removal of non-protein-bound and protein-bound uraemic solutes.
    De Smet R; Dhondt A; Eloot S; Galli F; Waterloos MA; Vanholder R
    Nephrol Dial Transplant; 2007 Jul; 22(7):2006-12. PubMed ID: 17468506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Blood level of middle molecular substances during uraemia and haemodialysis.
    Dzúrik R; Bozek P; Reznícek J; Oborníková A
    Proc Eur Dial Transplant Assoc; 1973; 10(0):263-70. PubMed ID: 4802412
    [No Abstract]   [Full Text] [Related]  

  • 47. The so-called "onion-like shape thromboelastogram" in dialyzed uraemic patients.
    Suchecki T
    Thromb Diath Haemorrh; 1974 Jun; 31(3):513-6. PubMed ID: 4424222
    [No Abstract]   [Full Text] [Related]  

  • 48. Adequate dialysis.
    Barber S; Appleton DR; Kerr DN
    Nephron; 1975; 14(2):209-27. PubMed ID: 1128745
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kinetics of phenols in body fluid compartments during hemodialysis.
    Erben J; Schück O; Brátová M; Moucka P; Palicka V; Fixa P; Hájková B; Herout V; Stilec R; Zahradník J
    Artif Organs; 1995 Jun; 19(6):544-6. PubMed ID: 8526794
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Removal of protein-bound uraemic toxins by haemodialysis.
    Niwa T
    Blood Purif; 2013; 35 Suppl 2():20-5. PubMed ID: 23676831
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of ferric polymaltose complex as a phosphate binder in haemodialysis patients.
    Chang JM; Hwang SJ; Tsai JC; Chen HC; Guh JY; Lai YH
    Nephrol Dial Transplant; 1999 Apr; 14(4):1045-7. PubMed ID: 10328515
    [No Abstract]   [Full Text] [Related]  

  • 52. Impairment of glutathione biosynthetic pathway in uraemia and dialysis.
    Alhamdani MS
    Nephrol Dial Transplant; 2005 Jan; 20(1):124-8. PubMed ID: 15632350
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evidence of red blood cell membrane lipid peroxidation in haemodialysis patients.
    Giardini O; Taccone-Gallucci M; Lubrano R; Ricciardi-Tenore G; Bandino D; Silvi I; Ruberto U; Casciani CU
    Nephron; 1984; 36(4):235-7. PubMed ID: 6709116
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum levels of immunoreactive gastric inhibitory polypeptide and insulin in uraemic patients.
    Matthaei D; Ebert R; Schauder P; Frerichs H; Creutzfeldt W; Scheler F
    Proc Eur Dial Transplant Assoc; 1977; 14():550-6. PubMed ID: 233949
    [No Abstract]   [Full Text] [Related]  

  • 55. Secondary hyperparathyroidism in uraemic patients on chronic haemodialysis--a case report and review.
    Lim YK
    Singapore Med J; 1973 Jun; 14(2):99-103. PubMed ID: 4741441
    [No Abstract]   [Full Text] [Related]  

  • 56. Interferon production by leucocytes of dialysed chronic uraemic patients.
    Gál G; Toth M; Toth S
    Proc Eur Dial Transplant Assoc; 1981; 18():188-92. PubMed ID: 6173878
    [No Abstract]   [Full Text] [Related]  

  • 57. Reduction of the homocysteine plasma concentration by intravenously administered folinic acid and vitamin B(12) in uraemic patients on maintenance haemodialysis.
    Buccianti G; Bamonti Catena F; Patrosso C; Corghi E; Novembrino C; Baragetti I; Lando G; De Franceschi M; Maiolo AT
    Am J Nephrol; 2001; 21(4):294-9. PubMed ID: 11509801
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuromuscular changes in uraemic patients treated with diet therapy and haemodialysis after successful renal transplantation.
    Ahonen RE; Kock B
    Proc Eur Dial Transplant Assoc; 1977; 14():568-70. PubMed ID: 341146
    [No Abstract]   [Full Text] [Related]  

  • 59. Long-term haemodialysis treatment with sodium removal by convection.
    Locatelli F; Pedrini L; Ponti R; Costanzo R; Di Filippo S; Marai P; Pozzi C; Bonacina GP
    Proc Eur Dial Transplant Assoc; 1981; 18():146-52. PubMed ID: 7329962
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysis.
    Shahapuni I; Esper NE; Opisiv R; Massy Z; Choukroun G; Garabedian M; Fournier A
    Nephrol Dial Transplant; 2008 Apr; 23(4):1456-7; author reply 1457-8. PubMed ID: 18039645
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.